AMD vs APUS · P/E 157, rev $11.54B vs $2.4M cap
Advanced Micro Devices Inc (AMD) versus Apimeds Pharmaceuticals US, Inc. (APUS) — a side-by-side from cached financials, not a winner call.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
APUS does not have a complete income-statement cache yet.
AMD currently screens at market cap $760.48B and trailing P/E 156.5. APUS currently screens at market cap $2.4M.
Not investment advice. Open the AMD and APUS stock pages for the full models.
Not investment advice.